Theriva Biologics (TOVX) Earnings Date & Reports

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TOVX is expected to report earnings to rise 10.00% to -5 cents per share on August 12

Theriva Biologics TOVX Stock Earnings Reports

Q2'26

Est.

$-0.05

Q1'26

Beat

by $0.16

Q4'25

Beat

by $1.17

Q3'25

Beat

by $0.68

Q2'25

Missed

by $0.85

The last earnings report on May 05 showed earnings per share of -5 cents, beating the estimate of -20 cents. With 185.20K shares outstanding, the current market capitalization sits at 11.61M.

View a ticker or compare two or three

Compare

TOVX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for TOVX